The drugmaker’s FDA filing, which covers adults 18 and older, followed a similar request by Pfizer-BioNTech on Monday. Pfizer requires permission for anyone 12 years of age or older.
Like Pfizer’s updated booster, Moderna’s so-called bivalent vaccine is specifically designed to fight the omicron BA.4 and BA.5 subvariants as well as the original strain of the coronavirus in a single dose. The move is underway FDA recommendation in June to modify vaccines to target the two subvariants.
While cases of COVID-19 are on the decline overall, experts worry that the trend could be reversed due to two new sub-variants.
To learn more about this story, go to NBC News.